Wells Fargo Downgrades Heartware (HTWR) to Market Perform Post FDA Approval
Tweet Send to a Friend
Wells Fargo downgraded Heartware Int'l (NASDAQ: HTWR) from Outperform to Market Perform and lowers its valuation range from $97-99 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
